Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Favus

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
The New England Journal of Medicine|November 30, 1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study GroupU A Liberman, S R Weiss, J Bröll, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
The New England Journal of Medicine|November 30, 1995
Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study GroupU A Liberman, S R Weiss, J Bröll, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of boneE Siris, R S Weinstein, R Altman, et al.
Pageof 2